Another study showed that TP53-mutated lung adenocarcinoma treated with ICIs showed significantly prolonged PFS (P=0.017, HR=0.69 [95%CI: 0.50-0.94]) (101). The gene discussed is TP53; the disease is lung adenocarcinoma.